Clinical Trials for Clear Cell Renal Cell Carcinoma

Find clinical trials for clear cell renal cell carcinoma. Discover research opportunities and treatment options in your area.

37 Active Trials Found

Showing 37 trials on this page

Page 2 of 2

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

NCT ID: NCT05663710

This clinical trial is investigating a new treatment approach for patients with advanced clear cell renal cell carcinoma (ccRCC), a type of kidney cancer. The study is looking at whether combining ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

NCT ID: NCT06750419

The ZIRCON-CP study is a clinical trial that is testing a new imaging agent called 89Zr-TLX250 for patients with clear cell renal cell carcinoma (ccRCC), a type of kidney cancer. This study is spec...

Recruiting

Phase: PHASE3 Type: interventional Locations: Beijing, , China, Beijing, , China +7 more

Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma

NCT ID: NCT06049576

This clinical trial is investigating the safety and effectiveness of combining two immunotherapy drugs, nivolumab and ipilimumab, with a natural supplement called camu camu for treating advanced ki...

Recruiting

Phase: PHASE1 Type: interventional Locations: Duarte, California, United States

A Phase 1/2 Trial of ADI-270 in CcRCC

NCT ID: NCT06480565

This clinical trial is testing a new treatment called ADI-270 for patients with clear cell renal cell carcinoma (ccRCC), which is a type of kidney cancer. The study aims to see how safe and effecti...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nashville, Tennessee, United States

Combination of Toripalimab and JS004 Therapy for ccRCC

NCT ID: NCT06690697

This clinical trial is testing a new treatment approach for patients with a type of kidney cancer called clear cell renal cell carcinoma (ccRCC) that has returned or spread after initial treatment....

Recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, , China, Shanghai, Shanghai, China

68Ga-C1 PET/ CT Imaging in Clear Cell Renal Cell Carcinoma

NCT ID: NCT06519760

This clinical trial is studying a new imaging test called 68Ga-C1 PET/CT to see how well it can help doctors identify and diagnose clear cell renal cell carcinoma, a type of kidney cancer. The rese...

Recruiting

Phase: NA Type: interventional Locations: Beijing, Beijing, China

[18F]PT2385 PET/CT in Patients with Renal Cell Carcinoma

NCT ID: NCT04989959

This clinical trial is exploring a new imaging technique called [18F]PT2385 Positron Emission Tomography/Computed Tomography (PET/CT) to better understand a protein called HIF2α in patients with re...

Recruiting

Phase: PHASE1 Type: interventional Locations: Dallas, Texas, United States

Evaluation of Urinary Exosomes Presence From Clear Cell Renal Cell Carcinoma

NCT ID: NCT04053855

This clinical trial is studying a new way to diagnose clear cell renal cell carcinoma, a type of kidney cancer. Currently, doctors often rely on expensive and invasive methods like imaging and biop...

Recruiting

Type: observational Locations: Saint étienne, , France

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC.

NCT ID: NCT06613269

This clinical trial is studying a new way to guide radiation therapy for patients with advanced clear cell renal cell carcinoma (ccRCC), which is a type of kidney cancer. Researchers are looking at...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

NCT ID: NCT05795595

The clinical trial titled "A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors" is exploring a new treatment called CTX131 for adults with certa...

Recruiting

Phase: PHASE1 Type: interventional Locations: Nashville, Tennessee, United States, Duarte, California, United States +5 more

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

NCT ID: NCT05433142

This clinical trial is studying a new treatment called XmAb®819 for patients with advanced clear cell renal cell carcinoma (ccRCC), a type of kidney cancer that has come back or has not responded t...

Recruiting

Phase: PHASE1 Type: interventional Locations: New York, New York, United States, Philadelphia, Pennsylvania, United States +8 more

Microbiota Transplant to Cancer Patients Who Have Failed Immunotherapy Using Faeces From Clinical Responders

NCT ID: NCT05286294

This clinical trial is studying the use of fecal microbiota transplant (FMT) to help cancer patients who have not responded to certain immunotherapy treatments. The idea is to take healthy bacteria...

Recruiting

Phase: PHASE2 Type: interventional Locations: Oslo, , Norway

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC

NCT ID: NCT06138496

This clinical trial is studying a new treatment approach for patients with a specific type of kidney cancer called clear cell renal cell carcinoma (ccRCC). The goal is to see if a combination of tw...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Other (Non U.S.), China, Guangzhou, , China

68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses

NCT ID: NCT05879510

This clinical trial is studying a new imaging test called 68Ga-NY104 PET/CT to help detect a type of kidney cancer known as clear cell renal cell carcinoma in patients who have kidney masses and ar...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion

NCT ID: NCT05879497

This clinical trial is studying a special imaging test called 68Ga-NY104 PET/CT to see how well it can detect clear cell renal cell carcinoma (ccRCC) that may have returned or spread to other parts...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma

NCT ID: NCT05214885

This clinical trial is investigating new biomarkers, which are substances in the body that can help detect and understand clear cell renal cell carcinoma (ccRCC), a common type of kidney cancer. Th...

Recruiting

Type: observational Locations: Jinan, , China

A Study of Sintilimab in Combination With Axitinib in Advanced Renal Cell Cancer

NCT ID: NCT04958473

This clinical trial is studying a new treatment approach for advanced renal cell carcinoma (a type of kidney cancer) by combining two medications: sintilimab and axitinib. The goal is to understand...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Tianjin, Tianjin, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions